[1] Barrangou R,Marraffini LA. CRISPR-Cas systems: prokaryotes upgrade to adaptive immunity[J]. Mol Cell,2014,54: 234-244. [2] Hille F,Richter H,Wong SP,et al. The biology of CRISPR-Cas: backward and forward[J]. Cell,2018,72: 1239-1259. [3] Hsu PD,Lander ES,Zhang F. Development and applica-tions of CRISPR-Cas9 for genome engineering[J]. Cell,2014,157: 1262-1278. [4] He B,Peng W,Huang J,et al. Modulation of metabolic functions through Cas13d-mediated gene knockdown in liver[J]. Protein Cell,2020,11: 518-524. [5] Konermann S,Lotfy P,Brideau NJ,et al. Transcriptome engineering with RNA-targeting type VI-D CRISPR effectors[J]. Cell,2018,173: 665-676. [6] Jiang W,Li H,Liu X,et al. Precise and efficient silencing of mutant Kras(G12D) by CRISPR-CasRx controls pancreatic cancer progression[J]. Theranostics,2020,10: 11507-11519. [7] Zhou H,Su J,Hu X,et al. Glia-to-neuron conversion by CRISPR-CasRx alleviates symptoms of neurological disease in mice[J]. Cell,2020,181: 590-603. [8] Mahas A,Aman R,Mahfouz M. CRISPR-Cas13d mediates robust RNA virus interference in plants[J]. Genome Biol,2019,20: 263-269. [9] Kushawah G,Hernandez-Huertas L,Abugattas-Nunez Del Prado J,et al.CRISPR-Cas13d induces efficient mRNA knockdown in animal embryos[J]. Dev Cell,2020,54: 805-817. [10] Wessels H,Mendez-Mancilla A,Guo X,et al. Massively parallel Cas13 screens reveal principles for guide RNA design[J]. Nat Biotechnol,2020,38: 722-727. [11] Li S,Li X,Xue W,et al. Screening for functional circular RNAs using the CRISPR-Cas13 system[J]. Nat Methods,2021,18: 51-59. [12] Ho NR,Usmani AR,Yin Y,et al. Multiplex shRNA screening of germ cell development by in vivo transfection of mouse testis[J]. G3 (Bethesda),2017,7: 247-255. |